Covered recipient · General Payments record
KALEY MICHELLE MARINO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$1,861.85
- Reported across 99 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $859.12 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $313.91 | 23 |
| E.R. Squibb & Sons, L.L.C. | $141.71 | 2 |
| Otsuka America Pharmaceutical, Inc. | $132.05 | 2 |
| Axsome Therapeutics, Inc. | $96.80 | 3 |
| Janssen Pharmaceuticals, Inc | $85.87 | 1 |
| Corium, Inc. | $57.66 | 2 |
| Almatica Pharma Inc. | $16.86 | 1 |
| Supernus Pharmaceuticals, Inc. | $14.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.26 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590669 | CMS |
| ABBVIE INC. | $27.50 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590671 | CMS |
| ABBVIE INC. | $19.62 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590673 | CMS |
| ABBVIE INC. | $9.77 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590675 | CMS |
| ABBVIE INC. | $9.87 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590677 | CMS |
| ABBVIE INC. | $1.86 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590679 | CMS |
| ABBVIE INC. | $26.57 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590681 | CMS |
| ABBVIE INC. | $30.97 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590683 | CMS |
| ABBVIE INC. | $14.45 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590685 | CMS |
| ABBVIE INC. | $34.50 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590687 | CMS |
| ABBVIE INC. | $5.69 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590689 | CMS |
| ABBVIE INC. | $4.98 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590691 | CMS |
| ABBVIE INC. | $8.07 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590693 | CMS |
| ABBVIE INC. | $21.51 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590695 | CMS |
| ABBVIE INC. | $6.19 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590697 | CMS |
| ABBVIE INC. | $13.06 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590699 | CMS |
| ABBVIE INC. | $10.72 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590701 | CMS |
| ABBVIE INC. | $9.02 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590703 | CMS |
| ABBVIE INC. | $10.61 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590705 | CMS |
| ABBVIE INC. | $10.54 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590707 | CMS |
| ABBVIE INC. | $6.59 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590709 | CMS |
| ABBVIE INC. | $18.97 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590711 | CMS |
| ABBVIE INC. | $6.59 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107590713 | CMS |
| Almatica Pharma LLC | $16.86 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137606448 | CMS |
| Axsome Therapeutics, Inc. | $33.03 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148373920 | CMS |
| Axsome Therapeutics, Inc. | $29.41 | 04/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148373922 | CMS |
| Axsome Therapeutics, Inc. | $34.36 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148373924 | CMS |
| Corium, LLC | $33.23 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100204530 | CMS |
| Corium, LLC | $24.43 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100190213 | CMS |
| E.R. Squibb & Sons, L.L.C. | $118.90 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101422966 | CMS |
| E.R. Squibb & Sons, L.L.C. | $22.81 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101422958 | CMS |
| Janssen Pharmaceuticals, Inc | $85.87 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078019542 | CMS |
| Otsuka America Pharmaceutical, Inc. | $30.96 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119129718 | CMS |
| Otsuka America Pharmaceutical, Inc. | $101.09 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119129720 | CMS |
| Supernus Pharmaceuticals, Inc. | $14.26 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147810931 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.